Envoy Medical Q2 EPS $(0.27) Misses $(0.25) Estimate, Sales $68.00K Miss $82.50K Estimate
Portfolio Pulse from Benzinga Newsdesk
Envoy Medical (NASDAQ:COCH) reported Q2 EPS of $(0.27), missing the $(0.25) estimate, and sales of $68.00K, missing the $82.50K estimate. Despite the misses, EPS improved by 79.39% and sales increased by 7.94% year-over-year.
August 12, 2024 | 12:45 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Envoy Medical (NASDAQ:COCH) reported Q2 EPS of $(0.27), missing the $(0.25) estimate, and sales of $68.00K, missing the $82.50K estimate. Despite the misses, EPS improved by 79.39% and sales increased by 7.94% year-over-year.
Envoy Medical's Q2 earnings and sales both missed analyst estimates, which is likely to negatively impact the stock price in the short term. However, the significant year-over-year improvement in EPS and sales may mitigate some of the negative sentiment.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100